Tye Sherilyn, Phillips Kathryn A, Liang Su-Ying, Haas Jennifer S
School of Pharmacy, University of California, San Francisco 94143, USA.
Health Serv Res. 2004 Feb;39(1):179-206. doi: 10.1111/j.1475-6773.2004.00221.x.
To develop a framework of factors to characterize health plans, to identify how plan characteristics were measured in a national survey, and to apply our findings to an analysis of the predictors of screening mammography.
The primary data were from the 1996 Medical Expenditure Panel Survey.
Women ages 40+, with private insurance, and no history of breast cancer were included in the study (N = 2,909). We used multivariate logistic regression to estimate mammography utilization in the past two years relative to health plan and demographic factors. Health plan measures included whether there is a defined provider network, whether coverage is restricted to a network, use of gatekeepers, level of cost containment, copayment and deductible amounts, coinsurance rate, and breadth of benefit coverage.
We found no significant difference in reported mammography utilization using a dichotomous comparison of individuals enrolled in managed care versus indemnity plans. However, women in health plans with a defined provider network were more likely to report having received a mammogram in the past two years than those without networks (adjusted OR= 1.21, 95 percent CI = 1.07-1.36), and women in gatekeeper plans were more likely to report receiving mammography than those without gatekeepers (adjusted OR = 1.18, 95 percent CI = 1.03-1.36). Restricted out-of-network coverage, use of cost containment, enrollee cost sharing, and breadth of benefit coverage did not appear to affect mammography use.
It is important to examine the effect of individual health plan components on the utilization of health care, rather than use the traditional broader categorizations of managed versus nonmanaged care or simple health plan typologies.
构建一个用于描述健康计划的因素框架,确定在一项全国性调查中如何衡量计划特征,并将我们的研究结果应用于分析乳腺钼靶筛查的预测因素。
主要数据来自1996年医疗支出小组调查。
研究纳入了年龄在40岁及以上、拥有私人保险且无乳腺癌病史的女性(N = 2909)。我们使用多元逻辑回归来估计过去两年中相对于健康计划和人口统计学因素的乳腺钼靶检查利用率。健康计划的衡量指标包括是否有明确的提供者网络、保险范围是否限于网络内、是否使用看门人制度、成本控制水平、共付额和免赔额金额、 coinsurance rate以及保险福利覆盖范围。
在对参加管理式医疗计划与赔偿计划的个体进行二分法比较时,我们发现报告的乳腺钼靶检查利用率没有显著差异。然而,与没有网络的女性相比,参加有明确提供者网络的健康计划的女性在过去两年中更有可能报告接受过乳腺钼靶检查(调整后的OR = 1.21,95%置信区间 = 1.07 - 1.36),并且参加看门人制度计划的女性比没有看门人制度的女性更有可能报告接受过乳腺钼靶检查(调整后的OR = 1.18,95%置信区间 = 1.03 - 1.36)。网络外保险范围受限、成本控制的使用、参保人的费用分担以及保险福利覆盖范围似乎并未影响乳腺钼靶检查的使用。
重要的是要研究个体健康计划组成部分对医疗保健利用的影响,而不是使用传统的更宽泛的管理式医疗与非管理式医疗分类或简单的健康计划类型。